ABSTRACT
INTRODUCTION: The number of tuberculosis cases in Finland has decreased. Cases among immigrants have, however, increased, and the disease may not be recognized early enough. METHODS: We describe four group exposures to tuberculosis that occurred in Finland, the index patient coming from a country with a high incidence rate of tuberculosis. RESULTS: Over 900 persons were exposed to tuberculosis. Coordination of the surveys was hampered by the fact that several healthcare operators participated in the study. Three index patients had drug-resistant tuberculosis, one of which was multidrug resistant. CONCLUSIONS: Extensive operations of tracking and prevention could have been avoided, if the symptoms would have been recognized earlier.
Subject(s)
Disease Outbreaks/prevention & control , Tuberculosis/epidemiology , Tuberculosis/transmission , Emigrants and Immigrants , Finland/epidemiology , Health Surveys , Humans , Incidence , Tuberculosis, Multidrug-Resistant/epidemiology , Tuberculosis, Multidrug-Resistant/transmissionABSTRACT
We describe an immunocompromised patient with disseminated Legionella pneumophila infection. A chronic leg ulcer was probably the port of entry for the infection. Treatment required several operations and prolonged antimicrobial treatment. To our knowledge, this is the first case report of Legionella soft tissue infection and pneumonia treated with tigecycline.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Legionella pneumophila/isolation & purification , Legionnaires' Disease/diagnosis , Legionnaires' Disease/drug therapy , Minocycline/analogs & derivatives , Humans , Immunocompromised Host , Leg Ulcer/complications , Legionnaires' Disease/pathology , Legionnaires' Disease/surgery , Male , Middle Aged , Minocycline/therapeutic use , Pneumonia/drug therapy , Pneumonia/microbiology , Pneumonia/surgery , Soft Tissue Infections/drug therapy , Soft Tissue Infections/microbiology , Soft Tissue Infections/surgery , TigecyclineABSTRACT
Administration of the BCG vaccine to all newborns was discontinued in Finland by the end of August 2006. Since then the vaccination has been given targetedly to children having an increased risk of contracting tuberculosis. We describe a child of six months and Finnish origin with diagnosed pulmonary tuberculosis. The child did not belong to any risk group and thus did not receive BCG vaccination as a newborn. Extensive investigations failed to reveal the source of infection.
